Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 10, 2012 - Issue 11
Submit an article Journal homepage
527
Views
21
CrossRef citations to date
0
Altmetric
Theme: Women & Cardiology - Review

Gender disparity in cardiovascular disease: bias or biology?

Nanette K Wenger Department of Medicine (Cardiology), Emory University School of Medicine, Consultant, Emory Heart and Vascular Center, Atlanta, GA, USA. [email protected]
Pages 1401-1411 | Published online: 10 Jan 2014

References

  • Heart Disease and Stroke Statistics 2011. Update: a Report from the American Heart Association. Circulation 123, e18–e209 (2011).
  • Adler NE, Adashi EY, Aguilar-Gaxiola S et al. Institute of Medicine’s (IOM) Committee on Women’s Health Research. Women’s Health Research: Progress, Pitfalls, and Promise. National Academies Press, Washington, DC, USA (2010).
  • Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378(9799), 1297–1305 (2011).
  • Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49(4), 403–414 (2007).
  • Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N. Engl. J. Med. 352(13), 1293–1304 (2005).
  • The Steering Committee of the Physicians’ Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoing physician’s health study. N. Engl. J. Med. 318(4), 262–264 (1988).
  • Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335(7627), 974 (2007).
  • McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am. Heart J. 156(5), 918–930 (2008).
  • Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet. Gynecol. 114(5), 961–970 (2009).
  • Fraser A, Nelson SM, Macdonald-Wallis C et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 125(11), 1367–1380 (2012).
  • Roberts JM, Hubel CA. Pregnancy: a screening test for later life cardiovascular disease. Womens. Health Issues 20(5), 304–307 (2010).
  • Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am. J. Med. 121(10 Suppl. 1), S3–S8 (2008).
  • Mosca L, Benjamin EJ, Berra K et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. Circulation 123(11), 1243–1262 (2011).
  • Daly C, Clemens F, Lopez Sendon JL et al.; Euro Heart Survey Investigators. Gender differences in the management and clinical outcome of stable angina. Circulation 113(4), 490–498 (2006).
  • Challenging existing paradigm in ischemic heart disease: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE). J. Am. Coll. Cardiol. 47(3), S1–S72 (2006).
  • Johnson BD, Shaw LJ, Pepine CJ et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur. Heart J. 27(12), 1408–1415 (2006).
  • Sharaf BL, Shaw L, Johnson D et al. Any measurable coronary artery disease identified in women presenting with ischemic chest pain is associated with an adverse outcome: findings from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Womens Ischemia Syndrome Evaluation (WISE) study angiographic core laboratory. J. Am. Coll. Cardiol. 43(5), 292A (2004).
  • Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA 293(4), 477–484 (2005).
  • Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E; for the TIDES Investigators. Characteristics of a contemporary population with angina pectoris. Am. J. Cardiol. 74(3), 226–231 (1994).
  • Olson MB, Kelsey SF, Matthews K et al. Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study. Eur. Heart J. 24(16), 1506–1514 (2003).
  • Jacobs AK. Women, ischemic heart disease, revascularization, and the gender gap: what are we missing? J. Am. Coll. Cardiol. 47(3 Suppl.), S63–S65 (2006).
  • Reynolds HR, Srichai MB, Iqbal SN et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 124(13), 1414–1425 (2011).
  • Banks K, Puttagunta D, Murphy S et al. Clinical characteristics, vascular function, and inflammation in women with angina in the absence of coronary atherosclerosis: the Dallas Heart Study. JACC. Cardiovasc. Imaging 4(1), 65–73 (2011).
  • Shaw LJ, Bairey Merz CN, Pepine CJ et al.; WISE Investigators. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J. Am. Coll. Cardiol. 47(3 Suppl.), S4–S20 (2006).
  • Bairey Merz CN, Shaw LJ, Reis SE et al.; WISE Investigators. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J. Am. Coll. Cardiol. 47(3 Suppl.), S21–S29 (2006).
  • Pepine CJ, Anderson RD, Sharaf BL et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J. Am. Coll. Cardiol. 55(25), 2825–2832 (2010).
  • Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J. Am. Coll. Cardiol. 54(17), 1561–1575 (2009).
  • Mehta PK, Goykhman P, Thomson LE et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC. Cardiovasc. Imaging 4(5), 514–522 (2011).
  • Pauly DF, Johnson BD, Anderson RD et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am. Heart J. 162(4), 678–684 (2011).
  • Jespersen L, Hvelplund A, Abildstrøm SZ et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur. Heart J. 33(6), 734–744 (2012).
  • Blomkalns AL, Chen AY, Hochman JS et al.; for the CRUSADE Investigators. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J. Am. Coll. Cardiol. 45(6), 832–837 (2005).
  • Alexander KP, Chen AY, Roe MT et al.; CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294(24), 3108–3116 (2005).
  • Alexander KP, Chen AY, Newby K et al.; for the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Investigators. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors. Results from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative. Circulation 114(13), 1380–1387 (2006).
  • Mega JL, Hochman JS, Scirica BM et al. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36). Circulation 121(16), 1809–1817 (2010).
  • Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N. Engl. J. Med. 341(4), 217–225 (1999).
  • Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch. Intern. Med. 169(19), 1767–1774 (2009).
  • Mallik S, Spertus JA, Reid KJ et al.; PREMIER Registry Investigators. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch. Intern. Med. 166(8), 876–883 (2006).
  • Jneid H, Fonarow GC, Cannon CP et al.; Get With the Guidelines Steering Committee and Investigators. Sex differences in medical care and early death after acute myocardial infarction. Circulation 118(25), 2803–2810 (2008).
  • Canto JG, Rogers WJ, Goldberg RJ et al.; NRMI Investigators. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 307(8), 813–822 (2012).
  • Dallongevillle J, De Bacquer D, Heidrich J et al.; EUROASPIRE Study Group. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart 96(21), 1744–1749 (2010).
  • Boden WE, O’Rourke RA, Teo KK et al.; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356(15), 1503–1516 (2007).
  • The BARI 2D Study Group. A randomized trial of therapies for Type 2 diabetes and coronary artery disease. N. Engl. J. Med. 360(24), 2503–2515 (2009).
  • Duvernoy CS, Smith DE, Manohar P et al. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. Am. Heart J. 159(4), 677–683.e1 (2010).
  • Mehran R, Pocock SJ, Nikolsky E et al. A risk score to predict bleeding in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 55(23), 2556–2566 (2010).
  • Mikhail GW, Gerber RT, Cox DA et al. Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the “TAXUS Woman” analysis. JACC. Cardiovasc. Interv. 3(12), 1250–1259 (2010).
  • Stefanini GG, Kalesan B, Pilgrim T et al. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC. Cardiovasc. Interv. 5(3), 301–310 (2012).
  • Lansky AJ, Hochman JS, Ward PA et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women. A statement for healthcare professionals from the American Heart Association. Circulation 111(7), 940–953 (2005).
  • Wright RS, Anderson JL, Adams CD et al. 2011 ACCF/AHA focused update of guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline). A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 57(19), 1920–1959 (2011).
  • Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery bypass surgery. Evidence for a higher mortality in younger women. Circulation 105(10), 1176–1181 (2002).
  • Hillis LD, Smith PK, Anderson JL et al. ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Executive Summary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 58(24), 2584–2614 (2011).
  • Puskas JD, Kilgo PD, Kutner M, Pusca SV, Lattouf O, Guyton RA. Off-pump techniques disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery bypass surgery. Circulation 116(11), I192–I199 (2007).
  • Humphries KH, Gao M, Pu A, Lichtenstein S, Thompson CR. Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J. Am. Coll. Cardiol. 49(14), 1552–1558 (2007).
  • Wenger NK. You’ve come a long way, baby: cardiovascular health and disease in women: problems and prospects. Circulation 109(5), 558–560 (2004).
  • Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch. Intern. Med. 162(15), 1682–1688 (2002).
  • Paulus WJ, Tschöpe C, Sanderson JE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 28(20), 2539–2550 (2007).
  • Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292(3), 344–350 (2004).
  • Ghali JK, Krause-Steinrauf HJ, Adams KF et al. Gender differences in advanced heart failure: insights from the BEST study. J. Am. Coll. Cardiol. 42(12), 2128–2134 (2003).
  • Hsich EM, Piña IL. Heart failure in women: a need for prospective data. J. Am. Coll. Cardiol. 54(6), 491–498 (2009).
  • O’Meara E, Clayton T, McEntegart MB et al.; CHARM Investigators. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 115(24), 3111–3120 (2007).
  • Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N. Engl. J. Med. 347(18), 1403–1411 (2002).
  • Bibbins-Domingo K, Lin F, Vittinghoff E et al. Predictors of heart failure among women with coronary disease. Circulation 110(11), 1424–1430 (2004).
  • Adams KF Jr, Fonarow GC, Emerman CL et al.; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am. Heart J. 149(2), 209–216 (2005).
  • Galvao M, Kalman J, DeMarco T et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J. Card. Fail. 12(2), 100–107 (2006).
  • Klein L, Grau-Sepulveda MV, Bonow RO et al. Quality of care and outcomes in women hospitalized for heart failure. Circ. Heart Fail. 4(5), 589–598 (2011).
  • Hernandez AF, Fonarow GC, Liang L et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 298(13), 1525–1532 (2007).
  • MacFadden DR, Crystal E, Krahn AD et al. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann. Intern. Med. 156(3), 195–203 (2012).
  • Goldenberg I, Moss AJ, Hall WJ et al.; MADIT-CRT Executive Committee. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 124(14), 1527–1536 (2011).
  • Bogaev RC, Pamboukian SV, Moore SA et al.; HeartMate II Clinical Investigators. Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation. J. Heart Lung Transplant. 30(5), 515–522 (2011).
  • Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc. Med. 18(5), 173–179 (2008).
  • Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int. J. Cardiol. 131(2), 168–179 (2009).
  • Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: a comprehensive review. Int. J. Cardiol. 118(3), 295–303 (2007).
  • Elkayam U, Tummala PP, Rao K et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N. Engl. J. Med. 344(21), 1567–1571 (2001).
  • Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 25(2), 242–249 (1995).
  • Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J. Am. Coll. Cardiol. 42(6), 1103–1107 (2003).
  • Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB; Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am. J. Cardiol. 94(7), 889–894 (2004).
  • Fang MC, Singer DE, Chang Y et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 112(12), 1687–1691 (2005).
  • Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J. Am. Coll. Cardiol. 49(5), 572–577 (2007).
  • Forleo GB, Tondo C, De Luca L et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 9(8), 613–620 (2007).
  • Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation 93(6), 1170–1176 (1996).
  • Wigginton JG, Pepe PE, Bedolla JP, DeTamble LA, Atkins JM. Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: a multiyear, prospective, population-based study. Crit. Care Med. 30(4 Suppl.), S131–S136 (2002).
  • Locati EH, Zareba W, Moss AJ et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 97(22), 2237–2244 (1998).
  • Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270(21), 2590–2597 (1993).
  • Benito B, Sarkozy A, Mont L et al. Gender differences in clinical manifestations of Brugada syndrome. J. Am. Coll. Cardiol. 52(19), 1567–1573 (2008).
  • Dhruva SS, Bero LA, Redberg RF. Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. Circ. Cardiovasc. Qual. Outcomes 4(2), 165–171 (2011).
  • The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med. 337(22), 1576–1583 (1997).
  • Bardy GH, Lee KL, Mark DB et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352(3), 225–237 (2005).
  • Zareba W, Moss AJ, Jackson Hall W et al.; MADIT II Investigators. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J. Cardiovasc. Electrophysiol. 16(12), 1265–1270 (2005).
  • Ghanbari H, Dalloul G, Hasan R et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 169(16), 1500–1506 (2009).
  • Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J. Interv. Card. Electrophysiol. 12(2), 107–113 (2005).
  • Lilli A, Ricciardi G, Porciani MC et al. Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. Pacing Clin. Electrophysiol. 30(11), 1349–1355 (2007).
  • Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women’s awareness of cardiovascular disease risk and barriers to heart health. Circ. Cardiovasc. Qual. Outcomes 3(2), 120–127 (2010).
  • Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 111(4), 499–510 (2005).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.